LOW-GRADE SEROUS OVARIAN CANCER
Clinical trials for LOW-GRADE SEROUS OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new LOW-GRADE SEROUS OVARIAN CANCER trials appear
Sign up with your email to follow new studies for LOW-GRADE SEROUS OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for Hard-to-Treat cancers
Disease control OngoingThis early-phase trial tests a combination of two experimental drugs, defactinib and VS-6766, in people with advanced solid tumors that have not responded to standard treatments. The study includes patients with certain lung, ovarian, pancreatic, and endometrial cancers. The main…
Matched conditions: LOW-GRADE SEROUS OVARIAN CANCER
Phase: PHASE1 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New hope for japanese women with rare ovarian cancer: drug combo shows promise
Disease control OngoingThis study tests a combination of two drugs, avutometinib and defactinib, in 16 Japanese patients whose low-grade serous ovarian cancer has come back after at least one round of platinum chemotherapy. The goal is to see if the drugs can shrink or control the tumors. Participants …
Matched conditions: LOW-GRADE SEROUS OVARIAN CANCER
Phase: PHASE2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC